Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-09-16 Sale |
2021-09-20 5:08 pm |
Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer |
5,736 | $6.73 | $38,603 | 14,264 (Direct) |
View |
| 2021-09-16 Sale |
2021-09-20 5:02 pm |
Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks |
5,736 | $6.73 | $38,603 | 14,264 (Direct) |
View |
| 2021-09-16 Sale |
2021-09-20 5:02 pm |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
6,238 | $6.73 | $41,982 | 13,762 (Direct) |
View |
| 2021-09-16 Sale |
2021-09-20 5:00 pm |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks |
14,340 | $6.73 | $96,508 | 938,954 (Indirect Direct) |
View |
| 2021-09-16 Sale |
2021-09-20 5:00 pm |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
6,103 | $6.73 | $41,073 | 13,897 (Direct) |
View |
| 2021-09-16 Sale |
2021-09-20 5:00 pm |
Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks |
5,736 | $6.73 | $38,603 | 14,264 (Direct) |
View |
| 2021-09-16 Sale |
2021-09-20 5:00 pm |
Magenta Therapeutics Inc. | MGTA | Nichols David Wayne Chief Technical Officer |
5,694 | $6.73 | $38,321 | 14,306 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-17 Option Award |
2022-05-19 4:23 pm |
N/A 2032-05-16 |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks |
162,500 | $0 | 162,500 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:22 pm |
N/A 2032-05-16 |
Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:20 pm |
N/A 2032-05-16 |
Magenta Therapeutics Inc. | MGTA | Nichols David Wayne Chief Technical Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:19 pm |
N/A 2032-05-16 |
Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks |
62,500 | $0 | 62,500 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:18 pm |
N/A 2032-05-16 |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:17 pm |
N/A 2032-05-16 |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:31 pm |
N/A 2032-02-14 |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks |
187,500 | $0 | 187,500 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:22 pm |
N/A 2032-02-14 |
Magenta Therapeutics Inc. | MGTA | Humphrey Jeffrey Chief Medical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:20 pm |
N/A 2032-02-14 |
Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:20 pm |
N/A 2032-02-14 |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:18 pm |
N/A 2032-02-14 |
Magenta Therapeutics Inc. | MGTA | Nichols David Wayne Chief Technical Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:17 pm |
N/A 2032-02-14 |
Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks |
100,000 | $0 | 100,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:16 pm |
N/A 2032-02-14 |
Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks |
130,000 | $0 | 130,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:15 pm |
N/A 2032-02-14 |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-10-01 Option Award |
2021-10-04 4:34 pm |
N/A 2031-09-30 |
Magenta Therapeutics Inc. | MGTA | Humphrey Jeffrey Chief Medical Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2021-08-26 Other |
2021-09-23 4:47 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Borisy Alexis Director |
4,100 | $0 | 8,200 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 7:43 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 7:42 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 7:41 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 7:41 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Mahoney Stephen F. See Remarks |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 7:40 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks |
50,000 | $0 | 953,294 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 7:39 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Nichols David Wayne Chief Technical Officer |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 7:39 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-08-25 Other |
2021-08-26 5:54 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Third Rock Ventures IV L.P. Third Rock Ventures GP IV L.P. TRV GP IV LLC 10% Owner |
1,250,000 | $0 | 8,008,204 (Direct) |
View |
| 2021-08-02 Option Award |
2021-08-03 4:39 pm |
N/A 2031-08-01 |
Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks |
12,500 | $0 | 12,500 (Direct) |
View |
| 2021-08-02 Option Award |
2021-08-03 4:34 pm |
N/A 2031-08-01 |
Magenta Therapeutics Inc. | MGTA | Stants Kristen Chief People Officer |
67,500 | $0 | 67,500 (Direct) |
View |
| 2021-08-02 Option Award |
2021-08-03 4:33 pm |
N/A 2031-08-01 |
Magenta Therapeutics Inc. | MGTA | GARDNER JASON See Remarks |
112,500 | $0 | 112,500 (Direct) |
View |
| 2021-07-20 Option Award |
2021-07-22 4:36 pm |
N/A 2031-07-19 |
Magenta Therapeutics Inc. | MGTA | Olson Lisa See Remarks |
50,000 | $0 | 50,000 (Direct) |
View |
| 2021-07-06 Option Award |
2021-07-08 4:33 pm |
N/A 2031-07-05 |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2021-07-08 4:32 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Deardorf Caren Chief Commercial Officer |
0 | $0 | 0 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-15 4:33 pm |
N/A 2031-06-13 |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2021-06-15 4:29 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
0 | $0 | 0 (Direct) |
View |